+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
AARTIDRUGS

Aarti Drugs Share Price

₹453.80 +18.6 (4.27%)
42.28% Gain from 52W Low

02 Nov, 2026 3:56 PM (IST)

Aarti Drugs live price: ₹453.80. It opened at ₹445 vs previous close ₹435; intraday high/low: ₹464/₹442. The 50 & 200 DMA stand at ₹415.60/₹408.10.

Aarti Drugs Performance

  • Today's Low
  • ₹442
  • Today's High
  • ₹464
  • 52 Week Low
  • ₹319
  • 52 Week High
  • ₹534
  • Open Price₹445
  • Previous Close₹435
  • Volume785,397
  • 50 DMA₹415.60
  • 100 DMA₹410.00
  • 200 DMA₹408.10

Aarti Drugs Chart

Investment Returns

  • Over 1 Month + 7.79%
  • Over 3 Month + 7.34%
  • Over 6 Month + 20.6%
  • Over 1 Year -7.6%

Smart Investing Starts Here Start SIP with Aarti Drugs for Steady Growth!

Invest Now

Aarti Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 21.7
  • PEG Ratio
  • 17.4
  • Market Cap Cr
  • 4,142
  • P/B Ratio
  • 2.6
  • Average True Range
  • 18.7
  • EPS
  • 20.9
  • Dividend Yield
  • 0.4
  • MACD Signal
  • 4
  • RSI
  • 64.4
  • MFI
  • 92.82

Latest Stock News Updates

Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Q2 H1 FY27 Earning Conference Call Intimation

Aarti Drugs Ltd - 524348 - Board Meeting Intimation for Audited Financial Results For The Quarter And Half Year Ended September 30, 2026

Aarti Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve Audited Financial Results for the quarter and half year ended September 30, 2026

Aarti Drugs Ltd - 524348 - Crisil ESG Rating

Intimation under Regulation 30 of SEBI LODR, 2015 - Crisil ESG Rating

Aarti Drugs Financials

Aarti Drugs Technicals

EMA & SMA

Current Price
₹453.80
+ 18.6 (4.27%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹417.10
  • 50 Day
  • ₹415.60
  • 100 Day
  • ₹410.00
  • 200 Day
  • ₹408.10

Resistance and Support

453.1 Pivot Speed
  • R3 485.80
  • R2 474.60
  • R1 464.20
  • S1 442.70
  • S2 431.50
  • S3 421.10

Aarti Drugs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-11-03 Quarterly Results
2026-08-27 Employees Stock Option Plan
2026-07-31 Quarterly Results
2026-05-15 Audited Results
2026-02-03 Quarterly Results & Interim Dividend
Date Purpose Remarks
2026-02-09 INTERIM Rs.2.00 per share(20%)Interim Dividend
2025-02-04 INTERIM Rs.1.00 per share(10%)Interim Dividend
2024-02-06 INTERIM Rs.1.00 per share(10%)Interim Dividend
2023-02-08 INTERIM Rs.1.00 per share(10%)Interim Dividend
2022-02-10 INTERIM Rs.1.00 per share(10%)Interim Dividend
View Aarti Drugs Dividend History Arrow

Aarti Drugs Shareholding Pattern

54.07%
33.42%
9.97%
2.26%
0.27%

About Aarti Drugs

Aarti Drugs is primarily involved in manufacturing and marketing of Active Pharmaceutical Ingredients (API), Pharma Intermediates and Specialty Chemicals. View More
  • NSE Symbol
  • AARTIDRUGS
  • BSE Symbol
  • 524348
  • Chairman.,Executive Director,Managing Director,Chief Executive Officer
  • Prakash M Patil
  • ISIN
  • INE767A01016

Similar Stocks to Aarti Drugs

Aarti Drugs FAQs

Aarti Drugs share price is ₹453 As on 03 November, 2026 | 02:57

The Market Cap of Aarti Drugs is ₹4141.8 Cr As on 03 November, 2026 | 02:57

The P/E ratio of Aarti Drugs is 21.7 As on 03 November, 2026 | 02:57

The PB ratio of Aarti Drugs is 2.6 As on 03 November, 2026 | 02:57

The 52 week High & Low of Aarti Drugs is ₹534/₹319 respectively As on 03 November, 2026 | 02:57

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23